![Tom Strange](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tom Strange
Private Equity Investor chez
iCON Infrastructure LLP
Profil
Tom Shaw Le Strange is currently a Director at iCON Infrastructure LLP.
Previously, he was a Director at MiroBio Ltd. in 2022.
He graduated from the University of Cambridge in 2012 and completed his undergraduate degree at The University of Nottingham in 2008.
Postes actifs de Tom Strange
| Sociétés | Poste | Début |
|---|---|---|
iCON Infrastructure LLP
 iCON Infrastructure LLP Investment ManagersFinance iCON Infrastructure invests in mid-market companies across Europe and North America. The firm targets companies operating in the fields of transportation, utilities, telecommunication, energy & environment and social infrastructure sectors. It provides financing for buyout transactions. | Private Equity Investor | 01/06/2023 |
Anciens postes connus de Tom Strange
| Sociétés | Poste | Fin |
|---|---|---|
MiroBio Ltd.
 MiroBio Ltd. BiotechnologyHealth Technology Develops therapeutics for auto-immune diseases | Private Equity Investor | 01/11/2022 |
Formation de Tom Strange
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
99
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iCON Infrastructure LLP
iCON Infrastructure LLP Investment ManagersFinance iCON Infrastructure invests in mid-market companies across Europe and North America. The firm targets companies operating in the fields of transportation, utilities, telecommunication, energy & environment and social infrastructure sectors. It provides financing for buyout transactions. | Finance |
MiroBio Ltd.
MiroBio Ltd. BiotechnologyHealth Technology Develops therapeutics for auto-immune diseases | Health Technology |
